# Memantine
*Source: TripSit Factsheets (tripsit.me)*

## Summary

An NMDA-antagonist that may produce a  prolonged dissociative "hole" experience lasting up to 16+ hours. The drug is used clinically to slow the progression of moderate-to-severe Alzheimer's disease, among other uses=.

## Classification
- **Categories:** dissociative, tentative

## Dosage

### Oral
- **Common:** 20-40mg
- **Heavy:** 40-80mg+
- **Light:** 10-20mg

## Duration
- **Onset:** 30-90 minutes
- **Duration:** 12-72 hours
- **After Effects:** 1-72 hours
